TreeWAS – Variant ID: rs2139424

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
Z22.3 Carrier of other specified bacterial diseases	0.000	0.944	0.056
Z22 Carrier of infectious disease	0.000	0.959	0.041
Z22.1 Carrier of other intestinal infectious diseases	0.000	0.965	0.035
Z22.5 Carrier of viral hepatitis	0.000	0.966	0.034
Z22.9 Carrier of infectious disease, unspecified	0.000	0.970	0.030
Z22.6 Carrier of human T-lymphotropic virus type 1 [HTLV-1] infection	0.000	0.970	0.030
Z22.4 Carrier of infections with a predominantly sexual mode of transmission	0.000	0.970	0.030
Z22.2 Carrier of diphtheria	0.000	0.970	0.030
Z22.0 Carrier of typhoid	0.000	0.970	0.030
C34.1 Upper lobe, bronchus or lung	0.029	0.971	0.000
Z22.8 Carrier of other infectious diseases	0.000	0.971	0.029
K91.8 Other postprocedural disorders of digestive system, not elsewhere classified	0.000	0.975	0.025
K91.3 Postoperative intestinal obstruction	0.000	0.978	0.022
K91 Postprocedural disorders of digestive system, not elsewhere classified	0.000	0.979	0.021
G12.2 Motor neuron disease	0.021	0.979	0.000
C34 Malignant neoplasm of bronchus and lung	0.020	0.980	0.000
C34.9 Bronchus or lung, unspecified	0.018	0.982	0.000
Z20-Z29 Persons with potential health hazards related to communicable diseases	0.000	0.982	0.017
C34.8 Overlapping lesion of bronchus and lung	0.017	0.983	0.000
K91.4 Colostomy and enterostomy malfunction	0.000	0.983	0.017
K91.1 Postgastric surgery syndromes	0.000	0.983	0.016
Z29 Need for other prophylactic measures	0.000	0.984	0.016
C34.2 Middle lobe, bronchus or lung	0.016	0.984	0.000
K91.5 Postcholecystectomy syndrome	0.000	0.984	0.015
K91.2 Postsurgical malabsorption, not elsewhere classified	0.000	0.984	0.015
C34.0 Main bronchus	0.015	0.985	0.000
Z29.1 Prophylactic immunotherapy	0.000	0.986	0.014
K91.9 Postprocedural disorder of digestive system, unspecified	0.000	0.986	0.014
K91.0 Vomiting following gastro-intestinal surgery	0.000	0.986	0.014
Z29.0 Isolation	0.000	0.987	0.013
Z29.2 Other prophylactic chemotherapy	0.000	0.987	0.013
Z28 Immunisation not carried out	0.000	0.987	0.013
Z27 Need for immunisation against combinations of infectious diseases	0.000	0.987	0.013
Z26 Need for immunisation against other single infectious diseases	0.000	0.987	0.013
Z25 Need for immunisation against other single viral diseases	0.000	0.987	0.013
Z23 Need for immunisation against single bacterial diseases	0.000	0.987	0.013
Z24 Need for immunisation against certain single viral diseases	0.000	0.987	0.013
Z29.9 Prophylactic measure, unspecified	0.000	0.988	0.012
Z20 Contact with and exposure to communicable diseases	0.000	0.989	0.011
G12 Spinal muscular atrophy and related syndromes	0.011	0.989	0.000
Z29.8 Other specified prophylactic measures	0.000	0.990	0.010
C30-C39 Malignant neoplasms of respiratory and intrathoracic organs	0.010	0.990	0.000
Z23.8 Need for immunisation against other single bacterial diseases	0.000	0.991	0.009
Z23.7 Need for immunisation against pertussis alone	0.000	0.991	0.009
Z23.6 Need for immunisation against diphtheria alone	0.000	0.991	0.009
Z23.5 Need for immunisation against tetanus alone	0.000	0.991	0.009
Z23.4 Need for immunisation against tularaemia	0.000	0.991	0.009
Z23.3 Need for immunisation against plague	0.000	0.991	0.009
Z23.2 Need for immunisation against tuberculosis [BCG]	0.000	0.991	0.009
Z23.1 Need for immunisation against typhoid-paratyphoid alone [TAB]	0.000	0.991	0.009
Z23.0 Need for immunisation against cholera alone	0.000	0.991	0.009
Z24.6 Need for immunisation against viral hepatitis	0.000	0.991	0.009
Z24.4 Need for immunisation against measles alone	0.000	0.991	0.009
Z24.3 Need for immunisation against yellow fever	0.000	0.991	0.009
Z24.2 Need for immunisation against rabies	0.000	0.991	0.009
Z24.1 Need for immunisation against arthropod-borne viral encephalitis	0.000	0.991	0.009
Z24.0 Need for immunisation against poliomyelitis	0.000	0.991	0.009
Z25.8 Need for immunisation against other specified single viral diseases	0.000	0.991	0.009
Z25.1 Need for immunisation against influenza	0.000	0.991	0.009
Z25.0 Need for immunisation against mumps alone	0.000	0.991	0.009
Z26.9 Need for immunisation against unspecified infectious disease	0.000	0.991	0.009
Z26.8 Need for immunisation against other specified single infectious diseases	0.000	0.991	0.009
Z26.0 Need for immunisation against leishmaniasis	0.000	0.991	0.009
Z27.9 Need for immunisation against unspecified combinations of infectious diseases	0.000	0.991	0.009
Z27.8 Need for immunisation against other combinations of infectious diseases	0.000	0.991	0.009
Z27.4 Need for immunisation against measles-mumps-rubella [MMR]	0.000	0.991	0.009
Z27.3 Need for immunisation against diphtheria-tetanus-pertussis with poliomyelitis [DTP + polio]	0.000	0.991	0.009
Z27.2 Need for immunisation against diphtheria-tetanus-pertussis with typhoid-paratyphoid [DTP + TAB]	0.000	0.991	0.009
Z27.1 Need for immunisation against diphtheria-tetanus-pertussis, combined [DTP]	0.000	0.991	0.009
Z27.0 Need for immunisation against cholera with typhoid-paratyphoid [cholera + TAB]	0.000	0.991	0.009
Z28.9 Immunisation not carried out for unspecified reason	0.000	0.991	0.009
Z28.8 Immunisation not carried out for other reasons	0.000	0.991	0.009
Z28.2 Immunisation not carried out because of patient's decision for other and unspecified reasons	0.000	0.991	0.009
Z28.1 Immunisation not carried out because of patient's decision for reasons of belief or group pressure	0.000	0.991	0.009
Z28.0 Immunisation not carried out because of contraindication	0.000	0.991	0.009
Z24.5 Need for immunisation against rubella alone	0.000	0.991	0.009
Z21 Asymptomatic human immunodeficiency virus [HIV] infection status	0.000	0.992	0.008
C30 Malignant neoplasm of nasal cavity and middle ear	0.008	0.992	0.000
Z20.9 Contact with and exposure to unspecified communicable disease	0.000	0.992	0.008
Z20.7 Contact with and exposure to pediculosis, acariasis and other infestations	0.000	0.992	0.008
Z20.6 Contact with and exposure to human immunodeficiency virus [HIV]	0.000	0.992	0.008
Z20.5 Contact with and exposure to viral hepatitis	0.000	0.992	0.008
Z20.4 Contact with and exposure to rubella	0.000	0.992	0.008
Z20.3 Contact with and exposure to rabies	0.000	0.992	0.008
Z20.2 Contact with and exposure to infections with a predominantly sexual mode of transmission	0.000	0.992	0.008
Z20.1 Contact with and exposure to tuberculosis	0.000	0.992	0.008
Z20.0 Contact with and exposure to intestinal infectious diseases	0.000	0.992	0.008
G12.9 Spinal muscular atrophy, unspecified	0.008	0.992	0.000
G12.8 Other spinal muscular atrophies and related syndromes	0.008	0.992	0.000
G12.1 Other inherited spinal muscular atrophy	0.008	0.992	0.000
G12.0 Infantile spinal muscular atrophy, type I [Werdnig-Hoffman]	0.008	0.992	0.000
C38 Malignant neoplasm of heart, mediastinum and pleura	0.008	0.992	0.000
C30.0 Nasal cavity	0.007	0.993	0.000
C39 Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs	0.007	0.993	0.000
C31 Malignant neoplasm of accessory sinuses	0.007	0.993	0.000
C33 Malignant neoplasm of trachea	0.007	0.993	0.000
C37 Malignant neoplasm of thymus	0.007	0.993	0.000
N50.1 Vascular disorders of male genital organs	0.000	0.993	0.007
A04.8 Other specified bacterial intestinal infections	0.007	0.993	0.000
C38.4 Pleura	0.006	0.993	0.000
Z20.8 Contact with and exposure to other communicable diseases	0.001	0.994	0.006
O47.9 False labour, unspecified	0.006	0.994	0.000
C30.1 Middle ear	0.006	0.994	0.000
L81.4 Other melanin hyperpigmentation	0.006	0.994	0.000
C38.8 Overlapping lesion of heart, mediastinum and pleura	0.006	0.994	0.000
C38.3 Mediastinum, part unspecified	0.006	0.994	0.000
C38.2 Posterior mediastinum	0.006	0.994	0.000
C38.1 Anterior mediastinum	0.006	0.994	0.000
C38.0 Heart	0.006	0.994	0.000
C31.9 Accessory sinus, unspecified	0.005	0.995	0.000
C31.8 Overlapping lesion of accessory sinuses	0.005	0.995	0.000
C31.3 Sphenoidal sinus	0.005	0.995	0.000
C31.2 Frontal sinus	0.005	0.995	0.000
C31.1 Ethmoidal sinus	0.005	0.995	0.000
C31.0 Maxillary sinus	0.005	0.995	0.000
C39.9 Ill-defined sites within the respiratory system	0.005	0.995	0.000
C39.8 Overlapping lesion of respiratory and intrathoracic organs	0.005	0.995	0.000
C39.0 Upper respiratory tract, part unspecified	0.005	0.995	0.000
C32 Malignant neoplasm of larynx	0.005	0.995	0.000
K14.8 Other diseases of tongue	0.000	0.995	0.005
O70.0 First degree perineal laceration during delivery	0.005	0.995	0.000
C34.3 Lower lobe, bronchus or lung	0.005	0.995	0.000
R61.9 Hyperhidrosis, unspecified	0.000	0.996	0.004
S02.10 Fracture of base of skull (closed)	0.004	0.996	0.000
C32.8 Overlapping lesion of larynx	0.004	0.996	0.000
C32.3 Laryngeal cartilage	0.004	0.996	0.000
C32.2 Subglottis	0.004	0.996	0.000
L81 Other disorders of pigmentation	0.004	0.996	0.000
N35.9 Urethral stricture, unspecified	0.000	0.996	0.004
S02.1 Fracture of base of skull	0.004	0.996	0.000
C32.1 Supraglottis	0.004	0.996	0.000
T51.0 Ethanol	0.000	0.996	0.004
L81.9 Disorder of pigmentation, unspecified	0.004	0.996	0.000
C32.0 Glottis	0.003	0.996	0.000
S02 Fracture of skull and facial bones	0.003	0.997	0.000
L81.2 Freckles	0.003	0.997	0.000
K29.1 Other acute gastritis	0.003	0.997	0.000
S02.4 Fracture of malar and maxillary bones	0.003	0.997	0.000
S02.3 Fracture of orbital floor	0.003	0.997	0.000
S02.2 Fracture of nasal bones	0.003	0.997	0.000
S02.11 Fracture of base of skull (open)	0.003	0.997	0.000
H33.0 Retinal detachment with retinal break	0.003	0.997	0.000
S02.30 Fracture of orbital floor (closed)	0.003	0.997	0.000
S02.40 Fracture of malar and maxillary bones (closed)	0.003	0.997	0.000
D86.0 Sarcoidosis of lung	0.003	0.997	0.000
G10-G14 Systemic atrophies primarily affecting the central nervous system	0.003	0.997	0.000
L81.0 Postinflammatory hyperpigmentation	0.003	0.997	0.000
L03.9 Cellulitis, unspecified	0.000	0.997	0.003
S02.6 Fracture of mandible	0.003	0.997	0.000
C32.9 Larynx, unspecified	0.003	0.997	0.000
L81.7 Pigmented purpuric dermatosis	0.003	0.997	0.000
L81.6 Other disorders of diminished melanin formation	0.003	0.997	0.000
L81.5 Leukoderma, not elsewhere classified	0.003	0.997	0.000
L81.3 Cafe au lait spots	0.003	0.997	0.000
L81.1 Chloasma	0.003	0.997	0.000
S02.20 Fracture of nasal bones (closed)	0.003	0.997	0.000
G70.0 Myasthenia gravis	0.000	0.997	0.003
E87.5 Hyperkalaemia	0.000	0.997	0.003
Q28.2 Arteriovenous malformation of cerebral vessels	0.003	0.997	0.000
C80.0 Malignant neoplasm, primary site unknown, so stated	0.000	0.997	0.003
N60.1 Diffuse cystic mastopathy	0.000	0.997	0.003
S02.21 Fracture of nasal bones (open)	0.003	0.997	0.000
S02.60 Fracture of mandible (closed)	0.003	0.997	0.000
S02.5 Fracture of tooth	0.003	0.997	0.000
S02.8 Fractures of other skull and facial bones	0.003	0.997	0.000
L81.8 Other specified disorders of pigmentation	0.003	0.997	0.000
S02.0 Fracture of vault of skull	0.003	0.997	0.000
K74.6 Other and unspecified cirrhosis of liver	0.000	0.997	0.003
S02.41 Fracture of malar and maxillary bones (open)	0.003	0.997	0.000
S02.31 Fracture of orbital floor (open)	0.002	0.997	0.000
T85.6 Mechanical complication of other specified internal prosthetic devices, implants and grafts	0.003	0.997	0.000
G13 Systemic atrophies primarily affecting central nervous system in diseases classified elsewhere	0.002	0.997	0.000
G14 Postpolio syndrome	0.002	0.997	0.000
G10 Huntington's disease	0.002	0.997	0.000
H02.5 Other disorders affecting eyelid function	0.003	0.997	0.000
K72.9 Hepatic failure, unspecified	0.000	0.997	0.003
D11.0 Parotid gland	0.000	0.997	0.003
S52.00 Fracture of upper end of ulna (closed)	0.000	0.997	0.003
D86 Sarcoidosis	0.003	0.997	0.000
S02.61 Fracture of mandible (open)	0.002	0.997	0.000
I82.9 Embolism and thrombosis of unspecified vein	0.003	0.997	0.000
N50 Other disorders of male genital organs	0.000	0.997	0.003
D86.1 Sarcoidosis of lymph nodes	0.002	0.997	0.000
K14.9 Disease of tongue, unspecified	0.000	0.997	0.003
R61 Hyperhidrosis	0.000	0.998	0.002
S02.50 Fracture of tooth (closed)	0.002	0.998	0.000
S02.7 Multiple fractures involving skull and facial bones	0.002	0.998	0.000
N50.0 Atrophy of testis	0.000	0.998	0.002
S02.51 Fracture of tooth (open)	0.002	0.998	0.000
S02.9 Fracture of skull and facial bones, part unspecified	0.002	0.998	0.000
S02.80 Fractures of other skull and facial bones (closed)	0.002	0.998	0.000
R61.0 Localised hyperhidrosis	0.000	0.998	0.002
T85.3 Mechanical complication of other ocular prosthetic devices, imnplants and grafts	0.002	0.998	0.000
S02.81 Fractures of other skull and facial bones (open)	0.002	0.998	0.000
D86.8 Sarcoidosis of other and combined sites	0.002	0.998	0.000
S02.01 Fracture of vault of skull (open)	0.002	0.998	0.000
F60.9 Personality disorder, unspecified	0.002	0.998	0.000
K08.9 Disorder of teeth and supporting structures, unspecified	0.000	0.998	0.002
S02.00 Fracture of vault of skull (closed)	0.002	0.998	0.000
I72.4 Aneurysm of artery of lower extremity	0.000	0.998	0.002
D18.0 Haemangioma, any site	0.000	0.998	0.002
G13.8 Systemic atrophy primarily affecting central nervous system in other diseases classified elsewhere	0.002	0.998	0.000
G13.2 Systemic atrophy primarily affecting central nervous system in myxoedema	0.002	0.998	0.000
G13.1 Other systemic atrophy primarily affecting central nervous system in neoplastic disease	0.002	0.998	0.000
G13.0 Paraneoplastic neuromyopathy and neuropathy	0.002	0.998	0.000
Q28 Other congenital malformations of circulatory system	0.002	0.998	0.000
R16.1 Splenomegaly, not elsewhere classified	0.000	0.998	0.002
D86.2 Sarcoidosis of lung with sarcoidosis of lymph nodes	0.002	0.998	0.000
N50.9 Disorder of male genital organs, unspecified	0.000	0.998	0.002
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.002	0.998	0.000
R16.2 Hepatomegaly with splenomegaly, not elsewhere classified	0.000	0.998	0.002
T47.1 Other antacids and anti-gastric-secretion drugs	0.002	0.998	0.000
M11.26 Other chondrocalcinosis (Lower leg)	0.002	0.998	0.000
O99.8 Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium	0.002	0.998	0.000
R61.1 Generalised hyperhidrosis	0.000	0.998	0.002
K14 Diseases of tongue	0.000	0.998	0.002
S02.71 Multiple fractures involving skull and facial bones (open)	0.002	0.998	0.000
D86.3 Sarcoidosis of skin	0.002	0.998	0.000
S82.30 Fracture of lower end of tibia (closed)	0.000	0.998	0.002
G11 Hereditary ataxia	0.002	0.998	0.000
S02.91 Fracture of skull and facial bones, part unspecified (open)	0.002	0.998	0.000
F42.9 Obsessive-compulsive disorder, unspecified	0.000	0.998	0.002
T36.0 Penicillins	0.002	0.998	0.000
F60 Specific personality disorders	0.002	0.998	0.000
K90-K93 Other diseases of the digestive system	0.000	0.998	0.002
O80.9 Single spontaneous delivery, unspecified	0.002	0.998	0.000
D80-D89 Certain disorders involving the immune mechanism	0.002	0.998	0.000
D84.8 Other specified immunodeficiencies	0.002	0.998	0.000
F60.7 Dependent personality disorder	0.002	0.998	0.000
H81.0 Meniere's disease	0.000	0.998	0.002
Y40.3 Macrolides	0.002	0.998	0.000
D84 Other immunodeficiencies	0.002	0.998	0.000
D89.9 Disorder involving the immune mechanism, unspecified	0.002	0.998	0.000
K10.3 Alveolitis of jaws	0.002	0.998	0.000
Q28.3 Other malformations of cerebral vessels	0.002	0.998	0.000
Z50.4 Psychotherapy, not elsewhere classified	0.000	0.998	0.002
K57.2 Diverticular disease of large intestine with perforation and abscess	0.000	0.998	0.002
Q28.9 Congenital malformation of circulatory system, unspecified	0.002	0.998	0.000
Q28.8 Other specified congenital malformations of circulatory system	0.002	0.998	0.000
Q28.1 Other malformations of precerebral vessels	0.002	0.998	0.000
U80.1 Methicillin resistant agent	0.000	0.998	0.002
K92.9 Disease of digestive system, unspecified	0.000	0.998	0.002
D83 Common variable immunodeficiency	0.002	0.998	0.000
H60.1 Cellulitis of external ear	0.002	0.998	0.000
I05.9 Mitral valve disease, unspecified	0.002	0.998	0.000
I20.1 Angina pectoris with documented spasm	0.002	0.998	0.000
Q28.0 Arteriovenous malformation of precerebral vessels	0.002	0.998	0.000
Y44.2 Anticoagulants	0.002	0.998	0.000
D83.9 Common variable immunodeficiency, unspecified	0.002	0.998	0.000
F60.8 Other specific personality disorders	0.002	0.998	0.000
K14.5 Plicated tongue	0.000	0.998	0.002
K14.4 Atrophy of tongue papillae	0.000	0.998	0.002
K14.3 Hypertrophy of tongue papillae	0.000	0.998	0.002
K14.2 Median rhomboid glossitis	0.000	0.998	0.002
K14.1 Geographic tongue	0.000	0.998	0.002
B97.8 Other viral agents as the cause of diseases classified to other chapters	0.002	0.998	0.000
F60.5 Anankastic personality disorder	0.002	0.998	0.000
N36.2 Urethral caruncle	0.000	0.998	0.002
Y40.4 Tetracyclines	0.002	0.998	0.000
F60.3 Emotionally unstable personality disorder	0.002	0.998	0.000
F60.0 Paranoid personality disorder	0.002	0.998	0.000
R40.0 Somnolence	0.002	0.998	0.000
T85.1 Mechanical complication of implanted electronic stimulator of nervous system	0.002	0.998	0.000
D80 Immunodeficiency with predominantly antibody defects	0.002	0.998	0.000
S02.70 Multiple fractures involving skull and facial bones (closed)	0.001	0.998	0.000
D84.1 Defects in the complement system	0.002	0.998	0.000
G11.8 Other hereditary ataxias	0.001	0.998	0.000
G11.3 Cerebellar ataxia with defective DNA repair	0.001	0.998	0.000
G11.2 Late-onset cerebellar ataxia	0.001	0.998	0.000
G11.1 Early-onset cerebellar ataxia	0.001	0.998	0.000
G11.0 Congenital nonprogressive ataxia	0.001	0.998	0.000
T36.3 Macrolides	0.002	0.998	0.000
W57.0 Home	0.002	0.998	0.000
R16 Hepatomegaly and splenomegaly, not elsewhere classified	0.000	0.998	0.002
F60.4 Histrionic personality disorder	0.002	0.998	0.000
F60.2 Dissocial personality disorder	0.002	0.998	0.000
F60.1 Schizoid personality disorder	0.002	0.998	0.000
D89 Other disorders involving the immune mechanism, not elsewhere classified	0.002	0.998	0.000
N35 Urethral stricture	0.000	0.998	0.002
N60.3 Fibrosclerosis of breast	0.000	0.998	0.002
Y40.9 Systemic antibiotic, unspecified	0.002	0.998	0.000
D82 Immunodeficiency associated with other major defects	0.002	0.998	0.000
D81 Combined immunodeficiencies	0.002	0.998	0.000
K93 Disorders of other digestive organs in diseases classified elsewhere	0.000	0.998	0.002
D80.1 Nonfamilial hypogammaglobulinaemia	0.002	0.998	0.000
T36 Poisoning by systemic antibiotics	0.002	0.998	0.000
S32.70 Multiple fractures of lumbar spine and pelvis (closed)	0.000	0.998	0.002
D84.0 Lymphocyte function antigen-1 [LFA-1] defect	0.001	0.998	0.000
S20.2 Contusion of thorax	0.002	0.998	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.002	0.998	0.000
T51 Toxic effect of alcohol	0.000	0.998	0.002
D89.1 Cryoglobulinaemia	0.001	0.998	0.000
Z48.8 Other specified surgical follow-up care	0.000	0.998	0.002
G70 Myasthenia gravis and other myoneural disorders	0.000	0.998	0.002
S02.90 Fracture of skull and facial bones, part unspecified (closed)	0.001	0.998	0.001
C79.8 Secondary malignant neoplasm of other specified sites	0.002	0.998	0.000
N20.9 Urinary calculus, unspecified	0.000	0.998	0.002
O86.0 Infection of obstetric surgical wound	0.000	0.998	0.002
Q27.3 Peripheral arteriovenous malformation	0.002	0.998	0.000
T50.6 Antidotes and chelating agents, not elsewhere classified	0.002	0.998	0.000
Q27 Other congenital malformations of peripheral vascular system	0.002	0.998	0.000
D83.8 Other common variable immunodeficiencies	0.001	0.998	0.000
D83.2 Common variable immunodeficiency with autoantibodies to B- or T-cells	0.001	0.998	0.000
D83.1 Common variable immunodeficiency with predominant immunoregulatory T-cell disorders	0.001	0.998	0.000
D83.0 Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function	0.001	0.998	0.000
I82.8 Embolism and thrombosis of other specified veins	0.002	0.998	0.000
O90.8 Other complications of the puerperium, not elsewhere classified	0.000	0.998	0.002
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.002	0.998	0.000
Y40.0 Penicillins	0.002	0.998	0.000
I82.3 Embolism and thrombosis of renal vein	0.001	0.998	0.000
M84.17 Nonunion of fracture [pseudarthrosis] (Ankle and foot)	0.002	0.998	0.000
C43.5 Malignant melanoma of trunk	0.002	0.998	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.001	0.998	0.000
D84.9 Immunodeficiency, unspecified	0.001	0.998	0.000
F60.6 Anxious [avoidant] personality disorder	0.001	0.998	0.000
G11.4 Hereditary spastic paraplegia	0.001	0.998	0.001
T46.1 Calcium-channel blockers	0.001	0.998	0.000
I82 Other venous embolism and thrombosis	0.002	0.998	0.000
Y40 Systemic antibiotics	0.002	0.998	0.000
D80.9 Immunodeficiency with predominantly antibody defects, unspecified	0.001	0.998	0.000
D80.8 Other immunodeficiencies with predominantly antibody defects	0.001	0.998	0.000
D80.7 Transient hypogammaglobulinaemia of infancy	0.001	0.998	0.000
D80.6 Antibody deficiency with near-normal immunoglobulins or with hyperimmunoglobulinaemia	0.001	0.998	0.000
D80.5 Immunodeficiency with increased immunoglobulin M [IgM]	0.001	0.998	0.000
D80.4 Selective deficiency of immunoglobulin M [IgM]	0.001	0.998	0.000
D80.0 Hereditary hypogammaglobulinaemia	0.001	0.998	0.000
T85.2 Mechanical complication of intraocular lens	0.001	0.998	0.000
Q20-Q28 Congenital malformations of the circulatory system	0.002	0.998	0.000
G96.0 Cerebrospinal fluid leak	0.001	0.998	0.000
R16.0 Hepatomegaly, not elsewhere classified	0.000	0.998	0.001
D89.8 Other specified disorders involving the immune mechanism, not elsewhere classified	0.001	0.999	0.000
D89.3 Immune reconstitution syndrome	0.001	0.999	0.000
Q25 Congenital malformations of great arteries	0.001	0.999	0.000
T85 Complications of other internal prosthetic devices, implants and grafts	0.001	0.999	0.000
D80.3 Selective deficiency of immunoglobulin G [IgG] subclasses	0.001	0.999	0.000
D82.9 Immunodeficiency associated with major defect, unspecified	0.001	0.999	0.000
D82.8 Immunodeficiency associated with other specified major defects	0.001	0.999	0.000
D82.4 Hyperimmunoglobulin E [IgE] syndrome	0.001	0.999	0.000
D82.3 Immunodeficiency following hereditary defective response to Epstein-Barr virus	0.001	0.999	0.000
D82.2 Immunodeficiency with short-limbed stature	0.001	0.999	0.000
D82.1 Di George's syndrome	0.001	0.999	0.000
D82.0 Wiskott-Aldrich syndrome	0.001	0.999	0.000
K14.6 Glossodynia	0.000	0.999	0.001
K93.8 Disorders of other specified digestive organs in diseases classified elsewhere	0.000	0.999	0.001
K93.1 Megacolon in Chagas' disease	0.000	0.999	0.001
K93.0 Tuberculous disorders of intestines, peritoneum and mesenteric glands	0.000	0.999	0.001
N35.1 Postinfective urethral stricture, not elsewhere classified	0.000	0.999	0.001
N35.0 Posttraumatic urethral stricture	0.000	0.999	0.001
Q25.4 Other congenital malformations of aorta	0.001	0.999	0.000
Q27.8 Other specified congenital malformations of peripheral vascular system	0.001	0.999	0.000
D81.9 Combined immunodeficiency, unspecified	0.001	0.999	0.000
D81.8 Other combined immunodeficiencies	0.001	0.999	0.000
D81.7 Major histocompatibility complex class II deficiency	0.001	0.999	0.000
D81.6 Major histocompatibility complex class I deficiency	0.001	0.999	0.000
D81.5 Purine nucleoside phosphorylase [PNP] deficiency	0.001	0.999	0.000
D81.4 Nezelof's syndrome	0.001	0.999	0.000
D81.3 Adenosine deaminase [ADA] deficiency	0.001	0.999	0.000
D81.2 Severe combined immunodeficiency [SCID] with low or normal B-cell numbers	0.001	0.999	0.000
D81.1 Severe combined immunodeficiency [SCID] with low T- and B-cell numbers	0.001	0.999	0.000
D81.0 Severe combined immunodeficiency [SCID] with reticular dysgenesis	0.001	0.999	0.000
H53.9 Visual disturbance, unspecified	0.000	0.999	0.001
S49.9 Unspecified injury of shoulder and upper arm	0.000	0.999	0.001
T36.9 Systemic antibiotic, unspecified	0.001	0.999	0.000
T36.8 Other systemic antibiotics	0.001	0.999	0.000
T36.7 Antifungal antibiotics, systemically used	0.001	0.999	0.000
T36.6 Rifamycins	0.001	0.999	0.000
T36.5 Aminoglycosides	0.001	0.999	0.000
T36.4 Tetracyclines	0.001	0.999	0.000
T36.2 Chloramphenicol group	0.001	0.999	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.001	0.999	0.000
T51.8 Other alcohols	0.000	0.999	0.001
T51.3 Fusel oil	0.000	0.999	0.001
T51.2 2-Propanol	0.000	0.999	0.001
T51.1 Methanol	0.000	0.999	0.001
C43.7 Malignant melanoma of lower limb, including hip	0.001	0.999	0.000
D80.2 Selective deficiency of immunoglobulin A [IgA]	0.001	0.999	0.000
G04.9 Encephalitis, myelitis and encephalomyelitis, unspecified	0.000	0.999	0.001
K10.2 Inflammatory conditions of jaws	0.001	0.999	0.000
Q27.9 Congenital malformation of peripheral vascular system, unspecified	0.001	0.999	0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.001	0.999	0.000
T46.8 Antivaricose drugs, including sclerosing agents	0.001	0.999	0.000
T46.7 Peripheral vasodilators	0.001	0.999	0.000
T46.4 Angiotensin-converting-enzyme inhibitors	0.001	0.999	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.001	0.999	0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.001	0.999	0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.001	0.999	0.000
O47 False labour	0.001	0.999	0.000
M10.99 Gout, unspecified (Site unspecified)	0.000	0.999	0.001
D86.9 Sarcoidosis, unspecified	0.001	0.999	0.000
D89.0 Polyclonal hypergammaglobulinaemia	0.001	0.999	0.000
G70.8 Other specified myoneural disorders	0.000	0.999	0.001
G70.2 Congenital and developmental myasthenia	0.000	0.999	0.001
G70.1 Toxic myoneural disorders	0.000	0.999	0.001
I82.0 Budd-Chiari syndrome	0.001	0.999	0.000
I98.2 Oesophageal varices in diseases classified elsewhere	0.000	0.999	0.001
Q25.6 Stenosis of pulmonary artery	0.001	0.999	0.000
Q27.4 Congenital phlebectasia	0.001	0.999	0.000
Q27.2 Other congenital malformations of renal artery	0.001	0.999	0.000
Q27.1 Congenital renal artery stenosis	0.001	0.999	0.000
Q27.0 Congenital absence and hypoplasia of umbilical artery	0.001	0.999	0.000
W02.9 Unspecified place	0.001	0.999	0.000
C80 Malignant neoplasm without specification of site	0.000	0.999	0.001
H60.9 Otitis externa, unspecified	0.001	0.999	0.000
I05.1 Rheumatic mitral insufficiency	0.001	0.999	0.000
E87.0 Hyperosmolality and hypernatraemia	0.000	0.999	0.001
G11.9 Hereditary ataxia, unspecified	0.001	0.999	0.000
H35.0 Background retinopathy and retinal vascular changes	0.000	0.999	0.001
I82.1 Thrombophlebitis migrans	0.001	0.999	0.000
N35.8 Other urethral stricture	0.000	0.999	0.001
O24.4 Diabetes mellitus arising in pregnancy	0.000	0.999	0.001
Q23.0 Congenital stenosis of aortic valve	0.001	0.999	0.000
T46.5 Other antihypertensive drugs, not elsewhere classified	0.001	0.999	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.001	0.999	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.001	0.999	0.000
T47.7 Emetics	0.001	0.999	0.000
T47.6 Antidiarrhoeal drugs	0.001	0.999	0.000
T47.5 Digestants	0.001	0.999	0.000
T47.4 Other laxatives	0.001	0.999	0.000
T47.3 Saline and osmotic laxatives	0.001	0.999	0.000
T47.2 Stimulant laxatives	0.001	0.999	0.000
T47.0 Histamine H(2)-receptor antagonists	0.001	0.999	0.000
T92.1 Sequelae of fracture of arm	0.001	0.999	0.000
Y40.7 Antifungal antibiotics, systemically used	0.001	0.999	0.000
Y40.6 Rifamycins	0.001	0.999	0.000
Y40.5 Aminoglycosides	0.001	0.999	0.000
Y40.2 Chloramphenicol group	0.001	0.999	0.000
M79.09 Rheumatism, unspecified (Site unspecified)	0.000	0.999	0.001
Q21.0 Ventricular septal defect	0.001	0.999	0.000
Q26 Congenital malformations of great veins	0.001	0.999	0.000
Q22 Congenital malformations of pulmonary and tricuspid valves	0.001	0.999	0.000
Q20 Congenital malformations of cardiac chambers and connexions	0.001	0.999	0.000
M76.87 Other enthesopathies of lower limb, excluding foot (Ankle and foot)	0.001	0.999	0.000
C83.0 Small cell (diffuse)	0.000	0.999	0.001
G70.9 Myoneural disorder, unspecified	0.000	0.999	0.001
Q25.9 Congenital malformation of great arteries, unspecified	0.001	0.999	0.000
Q25.8 Other congenital malformations of great arteries	0.001	0.999	0.000
Q25.7 Other congenital malformations of pulmonary artery	0.001	0.999	0.000
Q25.5 Atresia of pulmonary artery	0.001	0.999	0.000
Q25.3 Stenosis of aorta	0.001	0.999	0.000
Q25.2 Atresia of aorta	0.001	0.999	0.000
S52.0 Fracture of upper end of ulna	0.000	0.999	0.001
Z87.2 Personal history of diseases of the skin and subcutaneous tissue	0.001	0.999	0.000
N02.9 Unspecified	0.001	0.999	0.000
Q25.0 Patent ductus arteriosus	0.001	0.999	0.000
T85.8 Other complications of internal prosthetic devices, implants and grafts, not elsewhere classified	0.001	0.999	0.000
W50.0 Home	0.001	0.999	0.000
Z04.3 Examination and observation following other accident	0.000	0.999	0.001
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.001	0.999	0.000
M11.2 Other chondrocalcinosis	0.001	0.999	0.000
M76.86 Other enthesopathies of lower limb, excluding foot (Lower leg)	0.001	0.999	0.000
D18.1 Lymphangioma, any site	0.000	0.999	0.001
H49.2 Sixth [abducent] nerve palsy	0.000	0.999	0.001
Q21.9 Congenital malformation of cardiac septum, unspecified	0.001	0.999	0.000
T85.9 Unspecified complication of internal prosthetic device, implant and graft	0.001	0.999	0.000
C44.5 Skin of trunk	0.000	0.999	0.001
C80.9 Malignant neoplasm, unspecified	0.000	0.999	0.001
F64.0 Transsexualism	0.001	0.999	0.000
G96.1 Disorders of meninges, not elsewhere classified	0.001	0.999	0.000
K10.9 Disease of jaws, unspecified	0.001	0.999	0.000
W51.9 Unspecified place	0.001	0.999	0.000
W60.0 Home	0.001	0.999	0.000
Q23 Congenital malformations of aortic and mitral valves	0.001	0.999	0.000
Q21 Congenital malformations of cardiac septa	0.001	0.999	0.000
W57 Bitten or stung by non-venomous insect and other non-venomous arthropods	0.001	0.999	0.000
E29.1 Testicular hypofunction	0.000	0.999	0.001
G96.8 Other specified disorders of central nervous system	0.001	0.999	0.000
N32.0 Bladder-neck obstruction	0.000	0.999	0.001
Z50.5 Speech therapy	0.000	0.999	0.001
Q20.9 Congenital malformation of cardiac chambers and connexions, unspecified	0.001	0.999	0.000
Q20.8 Other congenital malformations of cardiac chambers and connexions	0.001	0.999	0.000
Q20.6 Isomerism of atrial appendages	0.001	0.999	0.000
Q20.5 Discordant atrioventricular connexion	0.001	0.999	0.000
Q20.4 Double inlet ventricle	0.001	0.999	0.000
Q20.3 Discordant ventriculoarterial connexion	0.001	0.999	0.000
Q20.2 Double outlet left ventricle	0.001	0.999	0.000
Q20.1 Double outlet right ventricle	0.001	0.999	0.000
Q20.0 Common arterial trunk	0.001	0.999	0.000
Q22.9 Congenital malformation of tricuspid valve, unspecified	0.001	0.999	0.000
Q22.8 Other congenital malformations of tricuspid valve	0.001	0.999	0.000
Q22.6 Hypoplastic right heart syndrome	0.001	0.999	0.000
Q22.5 Ebstein's anomaly	0.001	0.999	0.000
Q22.4 Congenital tricuspid stenosis	0.001	0.999	0.000
Q22.3 Other congenital malformations of pulmonary valve	0.001	0.999	0.000
Q22.2 Congenital pulmonary valve insufficiency	0.001	0.999	0.000
Q22.1 Congenital pulmonary valve stenosis	0.001	0.999	0.000
Q22.0 Pulmonary valve atresia	0.001	0.999	0.000
Q26.9 Congenital malformation of great vein, unspecified	0.001	0.999	0.000
Q26.8 Other congenital malformations of great veins	0.001	0.999	0.000
Q26.6 Portal vein-hepatic artery fistula	0.001	0.999	0.000
Q26.5 Anomalous portal venous connexion	0.001	0.999	0.000
Q26.4 Anomalous pulmonary venous connexion, unspecified	0.001	0.999	0.000
Q26.3 Partial anomalous pulmonary venous connexion	0.001	0.999	0.000
Q26.2 Total anomalous pulmonary venous connexion	0.001	0.999	0.000
Q26.1 Persistent left superior vena cava	0.001	0.999	0.000
Q26.0 Congenital stenosis of vena cava	0.001	0.999	0.000
S90.9 Superficial injury of ankle and foot, unspecified	0.001	0.999	0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.001	0.999	0.000
K10 Other diseases of jaws	0.001	0.999	0.000
G50.0 Trigeminal neuralgia	0.000	0.999	0.001
H25.8 Other senile cataract	0.000	0.999	0.001

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations